Viemed Healthcare (VMD) Liabilities and Shareholders Equity (2018 - 2026)

Viemed Healthcare (VMD) has 9 years of Liabilities and Shareholders Equity data on file, last reported at $197.4 million in Q1 2026.

• For the quarter ending Q1 2026, Liabilities and Shareholders Equity rose 10.83% year-over-year to $197.4 million; the trailing twelve-month figure through Mar 2026 stood at $783.5 million (up 13.77% YoY), and the FY2025 full-year result was $199.2 million, up 12.47% from the prior year.
• Liabilities and Shareholders Equity for Q1 2026 stood at $197.4 million, down from $199.2 million in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $202.4 million in Q3 2025 and bottomed at $115.9 million in Q2 2022.
• The 5-year median for Liabilities and Shareholders Equity is $154.9 million (2023), against an average of $157.4 million.
• The widest annual swing landed in 2022, when Liabilities and Shareholders Equity fell 0.78%; it then jumped 32.34% in 2023.
• A 5-year view of Liabilities and Shareholders Equity shows it stood at $117.0 million in 2022, then soared by 32.34% to $154.9 million in 2023, then gained by 14.32% to $177.1 million in 2024, then climbed by 12.47% to $199.2 million in 2025, then retreated by 0.9% to $197.4 million in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $197.4 million (Q1 2026), $199.2 million (Q4 2025), and $202.4 million (Q3 2025), per Business Quant data.

Peer Comparison